MDX-060

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MDX-060, covering 2010-04-26 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease [Phase 2]